When is splenectomy indicated for hereditary spherocytosis and what pre‑operative vaccinations and post‑operative prophylaxis are required?

Splenectomy in Hereditary Spherocytosis

For hereditary spherocytosis, splenectomy should be performed in patients with severe disease (hemoglobin <80 g/L, frequent transfusions, or symptomatic complications like cholelithiasis), ideally after age 5-6 years to minimize infection risk, with mandatory pre-operative pneumococcal, meningococcal, and Haemophilus influenzae type b vaccinations given at least 2 weeks before surgery, followed by lifelong prophylactic penicillin (especially critical in the first 2 years post-splenectomy). 1

Indications for Splenectomy

The decision to proceed with splenectomy in hereditary spherocytosis is based on disease severity and clinical impact:

Clear Indications:

• Severe anemia requiring frequent transfusions or hemoglobin persistently <80 g/L 2, 3
• Hemolytic crises requiring hospitalization 4
• Symptomatic cholelithiasis (present in 65.6% of HS cases) 2
• Growth retardation or failure to thrive
• Severe hyperbilirubinemia causing symptoms 4
• Splenomegaly causing abdominal pain or mechanical symptoms 3

Important Timing Consideration:

Delay splenectomy until after age 5-6 years whenever possible, as children under 5 have infection rates exceeding 10% post-splenectomy compared to <1% in adults 1. Recent data shows that HS patients actually have a higher risk of hospitalization for infections before splenectomy (OR 3.7) compared to controls, while post-splenectomy risk normalizes (OR 1.4) with appropriate prophylaxis 5. This supports earlier intervention in severely affected children when properly vaccinated.

Pre-operative Vaccination Protocol

Vaccinations must be administered at least 2 weeks before elective splenectomy to ensure optimal antibody response 1:

Required Vaccines:

• Pneumococcal vaccine (23-valent polysaccharide vaccine, >90% effective in adults <55 years) 1
• Meningococcal vaccine 1
• Haemophilus influenzae type b vaccine (critical as penicillin prophylaxis doesn't reliably cover H. influenzae) 1

Additional Recommended:

• Annual influenza vaccine to reduce risk of secondary bacterial infection 1

Post-operative Antibiotic Prophylaxis

Lifelong prophylactic antibiotics should be offered in all cases, with particular emphasis on the first 2 years when risk is highest 1:

Standard Regimen:

• Phenoxymethylpenicillin (penicillin V) daily as first-line 1
• Erythromycin for penicillin-allergic patients 1

Critical Caveats:

• Prophylaxis does not guarantee prevention of overwhelming post-splenectomy infection 1
• Penicillin does not cover H. influenzae, and amoxicillin coverage is unreliable 1
• Patients should keep home supply of amoxicillin for immediate use if fever develops 1
• Risk of fulminant infection is lifelong—cases reported >20 years post-splenectomy 1

Reimmunization Schedule

• Reimmunization every 5-10 years for pneumococcal vaccine 1
• Consider reimmunization as early as 2-3 years in high-risk patients, especially children <2 years who mount weaker initial responses 1

Surgical Considerations

Total vs. Partial Splenectomy:

Total splenectomy remains the gold standard for hereditary spherocytosis 3, 6. While partial splenectomy theoretically preserves immune function, it has significant limitations:

• High failure rate in young children requiring second operation for recurrent hypersplenism 7
• Splenic remnant regrowth is common in chronic hemolytic conditions 7
• Total splenectomy with proper vaccination/prophylaxis shows no increased infection risk in recent series 2, 5

Concurrent Cholecystectomy:

Prophylactic cholecystectomy should be performed in patients with marked hyperbilirubinemia (>4 mg/dL) even without visible stones, as cholelithiasis prevalence reaches 65.6% in HS 2. This is particularly justified given the high preoperative bilirubin levels in these patients.

Expected Outcomes

Post-splenectomy improvements are dramatic and durable 2, 3, 6:

• Hemoglobin increases by factor of 1.24 in HS
• Platelet counts increase by factor of 2.24
• Bilirubin levels decrease significantly
• Reticulocyte counts normalize
• Transfusion requirements eliminated

Patient Education Essentials

Patients must understand:

• Seek immediate medical attention for any febrile illness 1
• Carry medical alert card identifying asplenic status 1
• Require 5-day course of co-amoxiclav after any animal bite (risk of C. canimorsus) 1
• Notify all healthcare providers of splenectomy status
• General practitioner must be formally notified of splenectomy and vaccination record 1